Literature DB >> 6775767

Antibiotic sensitivities of gonococci isolated in Rotterdam and results of treatment with cefuroxime.

K C Nayyar, M F Michel, E Stolz.   

Abstract

In a study of the efficacy of cefuroxime in the treatment of 278 cases of acute gonorrhoea (including rectal and pharyngeal infections and infections due to penicillinase-producing Neisseria gonorrhoeae), high cure rates were found for both male (98.8%) and female patients (98.6%). Disadvantages of this treatment are its high cost and the relatively high proportion of patients who develop postgonococcal urethritis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6775767      PMCID: PMC1045789          DOI: 10.1136/sti.56.4.249

Source DB:  PubMed          Journal:  Br J Vener Dis        ISSN: 0007-134X


  6 in total

1.  Cefuroxime and post-gonococcal urethritis.

Authors:  W Fowler; G Rahim
Journal:  Proc R Soc Med       Date:  1977

2.  Sensitivity of gonococcus strains isolated in Rotterdam to epicillin, ampicillin, penicillin and tetracycline.

Authors:  E Stolz; M F Michel; J L Schuller; G A de Koning
Journal:  Dermatologica       Date:  1978

3.  Penicillinase-producing Neisseria gonorrhoeae.

Authors:  C W Phillips; R D Aller; S N Cohen
Journal:  Lancet       Date:  1976-10-30       Impact factor: 79.321

4.  Gonorrhea in Rotterdam caused by penicillinase-producing gonococci.

Authors:  K C Nayyar; R C Noble; M F Michel; E Stolz
Journal:  Br J Vener Dis       Date:  1980-08

5.  Sensitivity to ampicillin, penicillin, and tetracyline of gonococci in Rotterdam.

Authors:  E Stolz; H G Zwart; M F Michel
Journal:  Br J Vener Dis       Date:  1974-06

6.  Cefoxitin as a single-dose treatment for urethritis caused by penicillinase-producing Neisseria gonorrhoeae.

Authors:  S W Berg; M E Kilpatrick; W O Harrison; J A McCutchan
Journal:  N Engl J Med       Date:  1979-09-06       Impact factor: 91.245

  6 in total
  13 in total

1.  Treatment of uncomplicated urogenital gonorrhoea in women with a single dose of enoxacin.

Authors:  M J Tegelberg-Stassen; A H van der Willigen; J C van der Hoek; J H Wagenvoort; H J van Vliet; B van Klingeren; T van Joost; M F Michel; E Stolz
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

2.  Survey of cases of gonorrhoea caused by penicillinase producing Neisseria gonorrhoeae in the United Kingdom.

Authors:  M W Adler; J A McCutchan
Journal:  Genitourin Med       Date:  1985-02

3.  Gonorrhoea: a continuing problem in the 1980s.

Authors:  R N Thin
Journal:  Br J Vener Dis       Date:  1980-08

4.  Penicillinase-producing Neisseria gonorrhoeae in Riyadh, Saudi Arabia.

Authors:  M N Chowdhury; S S Pareek; E S Mahgoub
Journal:  Br J Vener Dis       Date:  1981-08

5.  Penicillin sensitivities of gonoccocci, in 1977-80 from a peripheral health district, and their clinical correlation.

Authors:  M Rahman
Journal:  Postgrad Med J       Date:  1982-02       Impact factor: 2.401

6.  Penicillinase-producing Neisseria gonorrhoeae in Great Britain, 1977-81: alarming increase in incidence and recent development of endemic transmission.

Authors:  J A McCutchan; M W Adler; J R Berrie
Journal:  Br Med J (Clin Res Ed)       Date:  1982-07-31

7.  Susceptibility to antimicrobials of Neisseria gonorrhoeae isolated in Singapore: implications on the need for more effective treatment regimens and control strategies.

Authors:  E H Sng; A L Lim; K L Yeo
Journal:  Br J Vener Dis       Date:  1984-12

8.  Comparison of oral treatment of uncomplicated urogenital and rectal gonorrhoea with cefuroxime axetil ester or clavulanic acid potentiated amoxycillin (Augmentin).

Authors:  R Schift; J van Ulsen; M C Ansink-Schipper; T van Joost; M F Michel; R K Woudstra; E Stolz
Journal:  Genitourin Med       Date:  1986-10

9.  Susceptibility of Neisseria gonorrhoeae to cefotaxime: in vitro studies and treatment results.

Authors:  U Neubert; H C Korting; G Ruckdeschel
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

Review 10.  Beta-lactams in sexually transmitted diseases: rationale for selection and dosing regimens.

Authors:  D Kunimoto; R Brunham; A Ronald
Journal:  Eur J Clin Microbiol       Date:  1984-12       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.